Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Hydrocortisone acetate+neomycin sulfate 1.5%/0.5% eye drops |
Is a |
Hydrocortisone topical preparation |
false |
Inferred relationship |
Some |
|
|
Hydrocortisone acetate+neomycin sulfate 1.5%/0.5% eye drops |
Is a |
Product containing neomycin in topical dosage form |
false |
Inferred relationship |
Some |
|
|
Hydrocortisone acetate+neomycin sulfate 1.5%/0.5% eye drops |
Is a |
Topical form compound hydrocortisone preparation |
false |
Inferred relationship |
Some |
|
|
Hydrocortisone acetate+neomycin sulfate 1.5%/0.5% eye drops |
Is a |
Miscellaneous eye preparations |
false |
Inferred relationship |
Some |
|
|
Hydrocortisone acetate+neomycin sulfate 1.5%/0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Topical neomycin |
false |
Inferred relationship |
Some |
|
|
Hydrocortisone acetate+neomycin sulfate 1.5%/0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Adrenal hormone |
false |
Inferred relationship |
Some |
|
|
Hydrocortisone acetate+neomycin sulfate 1.5%/0.5% eye drops |
Is a |
Product containing hydrocortisone and neomycin (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Hydrocortisone acetate+neomycin sulfate 1.5%/0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Hydrocortisone (substance) |
false |
Inferred relationship |
Some |
|
|
Hydrocortisone acetate+neomycin sulfate 1.5%/0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Neomycin sulfate |
false |
Inferred relationship |
Some |
|
|
Hydrocortisone acetate+neomycin sulfate 1.5%/0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Hydrocortisone acetate |
false |
Inferred relationship |
Some |
|
|
Hydrocortisone acetate+neomycin sulfate 1.5%/0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Corticosterone |
false |
Inferred relationship |
Some |
|
|
Hydrocortisone acetate+neomycin sulfate 1.5%/0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
anti-infectieux cutané |
false |
Inferred relationship |
Some |
|
|
Hydrocortisone acetate+neomycin sulfate 1.5%/0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Adrenal hormone agent |
false |
Inferred relationship |
Some |
|
|
Hydrocortisone acetate+neomycin sulfate 1.5%/0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Bactericide |
false |
Inferred relationship |
Some |
|
|
Hydrocortisone acetate+neomycin sulfate 1.5%/0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Local anti-infective |
false |
Inferred relationship |
Some |
|
|
Hydrocortisone acetate+neomycin sulfate 1.5%/0.5% eye drops |
Is a |
Product containing neomycin in ophthalmic dosage form |
false |
Inferred relationship |
Some |
|
|
Hydrocortisone acetate+neomycin sulfate 1.5%/0.5% eye drops |
Is a |
Product containing hydrocortisone in ocular dose form (medicinal product form) |
false |
Inferred relationship |
Some |
|
|
Hydrocortisone acetate+neomycin sulfate 1.5%/0.5% eye drops |
Has manufactured dose form |
Ocular dose form (dose form) |
false |
Inferred relationship |
Some |
|
|
Hydrocortisone acetate+neomycin sulfate 1.5%/0.5% eye drops |
Has manufactured dose form |
Eye drops |
false |
Inferred relationship |
Some |
|
|
Hydrocortisone acetate+neomycin sulfate 1.5%/0.5% eye drops |
Is a |
Product containing hydrocortisone acetate in ophthalmic dosage form |
false |
Inferred relationship |
Some |
|
|
Hydrocortisone acetate+neomycin sulfate 1.5%/0.5% eye drops |
Is a |
TEMPORARY parent for CDs that are not updated |
false |
Inferred relationship |
Some |
|
|